Slate Path Capital »

Teva Pharmaceutical Industries shares owned by Slate Path Capital

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Slate Path Capital from 13F filings

Historical chart of Slate Path Capital investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by Slate Path Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by Slate Path Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $243M 24M 10.20
2023-06-30 $94M 12M 7.53

More positions owned by Slate Path Capital

Western Digital (WDC)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
United States Steel Corporation (X)
Seagate Technology Hldngs Pl Ord Shs (STX)
Micron Technology (MU)
Teck Resources CL B (TECK)
Vaneck Etf Trust Gold Miners Etf (GDX)
Transocean Reg Shs (RIG)
Charter Communications Inc N Cl A (CHTR)
Kraneshares Tr Csi Chi Internet (KWEB)
Vaneck Etf Trust Junior Gold Mine (GDXJ)
Nov (NOV)
Cleveland-cliffs (CLF)
General Electric Com New (GE)
Chesapeake Energy Corp (CHK)

View all positions for Slate Path Capital

Top funds holding Teva Pharmaceutical Industries

Ion Asset Management
Phoenix Holdings
Migdal Insurance & Financial Holdings
Harel Insurance Investments & Financial Services
Millennium Management
Citadel Advisors
AustralianSuper Pty
Sound Shore Management
Goldman Sachs Group
Abrams Capital Management
Soleus Capital Management
Alyeska Investment Group
Legal & General Group
Holocene Advisors
Meitav Dash Investments

View all funds holding Teva Pharmaceutical Industries